Ishani Das

560 total citations
21 papers, 410 citations indexed

About

Ishani Das is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ishani Das has authored 21 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Immunology. Recurrent topics in Ishani Das's work include Melanoma and MAPK Pathways (9 papers), Cancer Immunotherapy and Biomarkers (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Ishani Das is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Cancer Immunotherapy and Biomarkers (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Ishani Das collaborates with scholars based in Sweden, United States and United Kingdom. Ishani Das's co-authors include Avinash Sonawane, Rojalin Sahu, Ranjit K. Mehta, Rashmirekha Pati, Rainer Tuominen, Herbert Cubasch, Alfred I. Neugut, Johan Hansson, Shane A. Norris and Judith S. Jacobson and has published in prestigious journals such as Molecular Cell, PLoS ONE and Scientific Reports.

In The Last Decade

Ishani Das

21 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ishani Das Sweden 9 168 98 75 52 49 21 410
Fengzhu Guo China 8 137 0.8× 79 0.8× 91 1.2× 94 1.8× 58 1.2× 22 394
Ya-Ling Yeh Taiwan 13 289 1.7× 65 0.7× 45 0.6× 88 1.7× 63 1.3× 13 461
Maude Fransolet Belgium 13 246 1.5× 66 0.7× 93 1.2× 54 1.0× 139 2.8× 22 545
Padideh Davoodpour Sweden 9 253 1.5× 75 0.8× 31 0.4× 118 2.3× 64 1.3× 12 473
Maria Goulielmaki Greece 14 257 1.5× 130 1.3× 31 0.4× 53 1.0× 122 2.5× 35 595
Yuya Yamaguchi Japan 13 139 0.8× 34 0.3× 45 0.6× 27 0.5× 32 0.7× 56 462
Xiaohan Sun China 15 326 1.9× 59 0.6× 42 0.6× 27 0.5× 92 1.9× 51 553
Rosa Mistica C. Ignacio South Korea 15 152 0.9× 138 1.4× 77 1.0× 41 0.8× 72 1.5× 26 590
Maria Mrakovcic Austria 12 347 2.1× 82 0.8× 62 0.8× 169 3.3× 42 0.9× 14 526
Bowen Liu China 12 256 1.5× 45 0.5× 37 0.5× 39 0.8× 47 1.0× 27 514

Countries citing papers authored by Ishani Das

Since Specialization
Citations

This map shows the geographic impact of Ishani Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ishani Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ishani Das more than expected).

Fields of papers citing papers by Ishani Das

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ishani Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ishani Das. The network helps show where Ishani Das may publish in the future.

Co-authorship network of co-authors of Ishani Das

This figure shows the co-authorship network connecting the top 25 collaborators of Ishani Das. A scholar is included among the top collaborators of Ishani Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ishani Das. Ishani Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McPherson, Lisa, Shanthi Adimoolam, David L. Wilson, et al.. (2025). Small-molecule activator of SMUG1 enhances repair of pyrimidine lesions in DNA. DNA repair. 146. 103809–103809. 2 indexed citations
2.
Wang, Aihui, Ishani Das, Ryan Bremer, et al.. (2025). RNA In Situ Hybridization Detection of CRTC1/3::MAML2 Fusions and LINC00473 in Mucoepidermoid Carcinomas and Hidradenomas of Breast, Salivary Glands, and Skin. Modern Pathology. 38(7). 100756–100756. 1 indexed citations
3.
Das, Ishani, et al.. (2025). Optimized Travelling Salesman Problem Solution Using 1-Tree Approach. 1–6. 1 indexed citations
4.
Wang, Aihui, Brooke Liang, Ishani Das, et al.. (2023). Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors. Modern Pathology. 36(11). 100318–100318. 2 indexed citations
5.
Srivastava, Ankit, et al.. (2022). Unravelling the landscape of skin cancer through single-cell transcriptomics. Translational Oncology. 27. 101557–101557. 8 indexed citations
6.
Das, Ishani, et al.. (2022). A Deep Learning-Based Approach for Adaptive Virtual Learning with Human Facial Emotion Detection. Journal of Student Research. 11(3). 1 indexed citations
7.
Onishi, Yoshiyuki, Lisa McPherson, Anna M. Kietrys, et al.. (2022). Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1. ACS Chemical Biology. 17(8). 2074–2087. 11 indexed citations
8.
Das, Ishani, Rainer Tuominen, Thomas Helleday, et al.. (2021). Coexpression of MTH1 and PMS2 Is Associated with Advanced Disease and Disease Progression after Therapy in Melanoma. Journal of Investigative Dermatology. 142(3). 736–740.e6. 6 indexed citations
9.
Vidarsdóttir, Linda, Alireza Azimi, Ishani Das, et al.. (2021). PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma. Scientific Reports. 11(1). 11023–11023. 10 indexed citations
10.
Das, Ishani, Helge Gad, Lars Bräutigam, et al.. (2020). AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma. Cell Death and Differentiation. 27(7). 2081–2098. 21 indexed citations
11.
Das, Ishani, Huiqin Chen, Gianluca Maddalo, et al.. (2020). Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma. Cell Death and Disease. 11(10). 882–882. 14 indexed citations
12.
Vidarsdóttir, Linda, Vasilios Zachariadis, Ishani Das, et al.. (2020). Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib. Melanoma Research. 30(5). 443–454. 4 indexed citations
13.
Das, Ishani, Margareta Wilhelm, Veronica Höiom, et al.. (2019). Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status. Cell Death and Disease. 10(9). 663–663. 20 indexed citations
14.
Svedman, Fernanda Costa, Ishani Das, Rainer Tuominen, et al.. (2019). Genes involved in DNA replication, chromatin remodeling and cell cycle as potential biomarkers for therapy outcome to immune therapy in patients with metastatic cutaneous malignant melanoma. Annals of Oncology. 30. v559–v559. 1 indexed citations
15.
Tsang, Chi Kwan, Miao Chen, Xin Cheng, et al.. (2018). SOD1 Phosphorylation by mTORC1 Couples Nutrient Sensing and Redox Regulation. Molecular Cell. 70(3). 502–515.e8. 90 indexed citations
16.
Joffe, Maureen, Oluwatosin Ayeni, Shane A. Norris, et al.. (2018). Barriers to early presentation of breast cancer among women in Soweto, South Africa. PLoS ONE. 13(2). e0192071–e0192071. 68 indexed citations
17.
Das, Ishani, Helge Gad, Lars Bräutigam, et al.. (2018). 1180 Effects of MTH1 inhibitor TH1579 on cutaneous melanoma. Journal of Investigative Dermatology. 138(5). S200–S200. 2 indexed citations
18.
Das, Ishani, et al.. (2017). Biocompatible Chitosan Nanoparticles as an Efficient Delivery Vehicle for Mycobacterium Tuberculosis Lipids to Induce Potent Cytokines and Antibody Response through Activation of γδ T-Cells in Mice. 4(1). 2 indexed citations
19.
20.
Pati, Rashmirekha, Ishani Das, Ranjit K. Mehta, Rojalin Sahu, & Avinash Sonawane. (2016). Zinc-Oxide Nanoparticles Exhibit Genotoxic, Clastogenic, Cytotoxic and Actin Depolymerization Effects by Inducing Oxidative Stress Responses in Macrophages and Adult Mice. Toxicological Sciences. 150(2). 454–472. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fengzhu Guo Breakdown of academic impact, for papers by Ya-Ling Yeh Breakdown of academic impact, for papers by Maude Fransolet Breakdown of academic impact, for papers by Padideh Davoodpour Breakdown of academic impact, for papers by Maria Goulielmaki Breakdown of academic impact, for papers by Yuya Yamaguchi Breakdown of academic impact, for papers by Xiaohan Sun Breakdown of academic impact, for papers by Rosa Mistica C. Ignacio Breakdown of academic impact, for papers by Maria Mrakovcic Breakdown of academic impact, for papers by Bowen Liu
Rankless by CCL
2026